Mutual fund · AMFI 119775
Kotak Emerging Equity Fund
NAV ₹165.94 · 17 Nov 2026
Kotak Emerging Equity Fund is a mid cap mutual fund run by Kotak. Its NAV was ₹165.94 on 17 Nov 2026, up 3.0% over one year and 15.5% a year over three years. The top 10 holdings made up 28.6% of the portfolio in October 2026.
Returns from NAV
One year and shorter are absolute; three and five years are annualised. Based on NAV, so dividend payouts are not added back. Past performance does not guarantee future results.
Risk · last 3.0 years
How bumpy the ride has been
Worked out from weekly NAVs. The largest fall ran from 11 Dec 2024 to 28 Feb 2025. Sharpe and Sortino use a fixed 6.5% a year risk-free rate for comparison. Past figures are not a guide to future returns.
Portfolio · October 2026
Top holdings (72 in total)
| Company | % of fund | vs last month |
|---|---|---|
| IPCA Laboratories Ltd. | +0.11 | |
| Fortis Healthcare India Ltd | +0.13 | |
| Mphasis Ltd | +0.53 | |
| FEDERAL BANK LTD. | +0.3 | |
| L&T FINANCE LTD | 0.0 | |
| VISHAL MEGA MART LIMITED | -0.42 | |
| Dixon Technologies India Ltd | -0.31 | |
| INDIAN BANK | +0.24 | |
| BANK OF MAHARASHTRA | +0.31 | |
| GE VERNOVA T&D INDIA LIMITED | -0.04 | |
| BHARTI HEXACOM LTD. | +0.37 | |
| Solar Industries India Limited | -0.09 | |
| KEI Industries Ltd. | -0.17 | |
| Gland Pharma Limited | +0.64 | |
| Schaeffler India Ltd | -0.13 |
The top 10 make up 28.6% of the fund. Source: the fund house's monthly portfolio disclosure.
Since September 2026
What changed
No holding changed by 1 percentage point or more.
By sector
Where the money is
Finance9.9%
Pharmaceuticals and Biotechnology9.7%
Healthcare Services8.8%
Banks8.7%
IT - Software7.4%
Auto Components7.0%
Equity: Mid Cap
Other funds in this category
Six large funds in the same category, listed for comparison only.
Learn more
Mutual fund guides
Your mutual funds
Review your own mutual fund portfolio
Upload or fetch your holdings and see each fund's returns, cost and overlap against benchmarks, as facts. Review my mutual funds
Questions
About Kotak Emerging Equity Fund
What is the NAV of Kotak Emerging Equity Fund?
The net asset value was Rs 165.94 on 17 November 2026.
What is the expense ratio of Kotak Emerging Equity Fund?
The latest expense ratio is not available in our data yet.
What is the one-year return of Kotak Emerging Equity Fund?
The NAV changed by 3.0% over the last year; past returns do not indicate future returns.
Data: AMFI NAVs and expense ratios and the fund house's monthly portfolio disclosures. This page states facts and is not a recommendation to buy or sell. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not guarantee future results.